NEW YORK, Nov. 10, 2017 —
If you want a Stock Review on SENS, XTNT, NVCR, or VAR then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Today, DailyStockTracker.com redirects investors' attention to the Medical Appliances and Equipment industry, which primarily offers equipment and devices that are designed for the diagnosis, monitoring, and treatment of patients in healthcare systems worldwide. Lined up for assessment are: Senseonics Holdings Inc. (NYSE AMER: SENS), Xtant Medical Holdings Inc. (NYSE AMER: XTNT), NovoCure Ltd (NASDAQ: NVCR), and Varian Medical Systems Inc. (NYSE: VAR). These free stocks reports are currently available on DailyStockTracker.com. Simply sign up for your complimentary member access at: http://dailystocktracker.com/register/
Germantown, Maryland headquartered Senseonics Holdings Inc.'s stock finished Thursday's session 0.38% higher at $2.63 with a total trading volume of 298,109 shares. Over the previous three months, the Company's shares have advanced 5.62%. The stock is trading above its 200-day moving average by 16.72%. Moreover, shares of Senseonics, which designs, develops, and commercializes glucose monitoring systems for people with diabetes primarily in Europe, have a Relative Strength Index (RSI) of 43.23.
On October 31st, 2017, Senseonics reported financial results for Q3 ended September 30th, 2017. Revenue was $2.1 million for Q3 2017, sales and marketing expenses increased to $2.1 million, and net loss was $17.4 million. As of September 30th, 2017, cash, cash equivalents, and marketable securities were $52.7 million, and outstanding indebtedness was $25 million. Your complete research report on SENS can be retrieved for free at: http://dailystocktracker.com/registration/?symbol=SENS
Xtant Medical Holdings
Shares in Belgrade, Montana headquartered Xtant Medical Holdings Inc. rose 0.45%, ending yesterday's session at $0.69 with a total trading volume of 223,129 shares. The stock has gained 25.45% on an YTD basis. The Company's shares are trading 10.40% above their 200-day moving average. Moreover, shares of Xtant Medical, which develops, manufactures, and markets regenerative medicine products and devices in the US and internationally, have an RSI of 45.82. A free report on XTNT is just a click away at: http://dailystocktracker.com/registration/?symbol=XTNT
On Thursday, Saint Helier, the Channel Islands-based NovoCure Ltd's stock saw a correction of 4.18%, to close the day at $18.35. A total volume of 1.45 million shares was traded, which was above their three months average volume of 938,150 shares. The Company's shares have advanced 0.27% in the last one month, 0.27% in the previous three months, and 133.76% on an YTD basis. The stock is trading 25.72% above its 200-day moving average. Additionally, shares of NovoCure, which engages in the development, manufacture, and commercialization of tumor treating fields for the treatment of solid tumors, have an RSI of 40.27.
On November 08th, 2017, NovoCure announced 13 preclinical presentations highlighting data on Tumor Treating Fields' mechanism of action at the 22nd Annual Meeting of the Society for Neuro-Oncology (SNO), to be held from November 16th, 2017, through November 19th, 2017 in San Francisco. These 13 preclinical presentations add to the six clinical data presentations to be shared at SNO this year. In total, 60 abstracts on Tumor Treating Fields, including two oral presentations, will be presented. Sign up for your complimentary research report on NVCR at: http://dailystocktracker.com/registration/?symbol=NVCR
Varian Medical Systems
Shares in Palo Alto, California headquartered Varian Medical Systems Inc. ended the day 0.08% higher at $107.69. A total volume of 718,958 shares was traded. The stock has gained 6.72% in the last one month, 10.18% in the previous three months, and 35.45% since the start of this year. The Company's shares are trading above their 50-day and 200-day moving averages by 2.97% and 11.27%, respectively. Furthermore, shares of the Company, which designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide, have an RSI of 59.21.
On October 30th, 2017, Varian Medical Systems announced that it has named Terilyn Juarez Monroe as Chief People Officer, Senior Vice-President – Human Resources, effective that day. Ms. Monroe, 50, is replacing Wendy Scott, who is retiring after serving in this same role after 13 years. Register for free on DailyStockTracker.com and download the latest research report on VAR at: http://dailystocktracker.com/registration/?symbol=VAR
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://dailystocktracker.com/disclaimer/
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: (207)-331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Latest posts by Sarah Thompson (see all)
- Stefanie Smith Named Chief Clinical Officer for Hanna Boys Center - February 18, 2018